Literature DB >> 8819537

Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.

P M Friden1, T S Olson, R Obar, L R Walus, S D Putney.   

Abstract

Monoclonal antibodies to the human transferrin receptor were screened for binding to capillary vessels in human, monkey, rabbit and rat brain tissue. Two antibodies were selected that bind both human and monkey but not rabbit or rat microvessels. With recombinant fragments of the human receptor, both antibodies were shown to bind to a region of the extracellular portion of the receptor that is relatively variable among species. Binding, which was characterized by using purified receptor and K562 cells, was not reduced by excess transferrin, indicating that the antibodies bind the receptor at a site different from that of transferrin. When the antibodies were radiolabeled and injected i.v. into cynomolgous monkeys, they distributed selectively to brain but not to other organs or tissues. The antibodies were found almost exclusively in the brain parenchyma, rather than the capillaries, indicating that they had transcytosed the blood-brain barrier. These results show that antibodies to the human transferrin receptor cross the blood-brain barrier and may be useful for noninvasive delivery of therapeutic proteins to the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8819537

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

Review 1.  Determinants of passive drug entry into the central nervous system.

Authors:  M D Habgood; D J Begley; N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  Blood-brain barrier transport of therapeutics via receptor-mediation.

Authors:  Angela R Jones; Eric V Shusta
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

3.  Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.

Authors:  Devin T Wiley; Paul Webster; Aaron Gale; Mark E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

4.  Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium.

Authors:  H Xia; B Anderson; Q Mao; B L Davidson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 5.  Transferrin and transferrin receptor function in brain barrier systems.

Authors:  T Moos; E H Morgan
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

6.  Revisiting intra-arterial drug delivery for treating brain diseases or is it "déjà-vu, all over again"?

Authors:  Shailendra Joshi; Jason A Ellis; Charles W Emala
Journal:  J Neuroanaesth Crit Care       Date:  2014-05

7.  Presence of GAD65 autoantibodies in the serum of children with autism or ADHD.

Authors:  Ujjwal K Rout; Nils K Mungan; Dirk M Dhossche
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-10       Impact factor: 4.785

8.  Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.

Authors:  Anita Schnyder; Stefan Krähenbühl; Michael Török; Jürgen Drewe; Jörg Huwyler
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

Review 9.  Strategies for increasing drug delivery to the brain: focus on brain lymphoma.

Authors:  Tali Siegal; Ester Zylber-Katz
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 5.577

10.  A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding.

Authors:  Hadassah Sade; Claudia Baumgartner; Adrian Hugenmatter; Ekkehard Moessner; Per-Ola Freskgård; Jens Niewoehner
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.